Knockdown of hypoxia-inducible factor-1α by siRNA inhibits C2C12 myoblast differentiation

Journal of Cellular Biochemistry

Volumn 98, Issue 3, 2006, Pages 642-649

  Ono, Yusuke ^a   Sensui, Hiroomi ^b   Sakamoto, Yuzuru ^c   Nagatomi, Ryoichi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b PHYSICAL FITNESS RESEARCH INSTITUTE   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

HIF 1 ; HSP90; Myogenesis

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BETA TUBULIN; GELDANAMYCIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MYOGENIN; MYOSIN HEAVY CHAIN; PROTEASOME INHIBITOR; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; EXERCISE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN RNA BINDING; PROTEIN STABILITY; REGULATORY MECHANISM; TISSUE REGENERATION;

ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HSP90 HEAT-SHOCK PROTEINS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MUSCLE DEVELOPMENT; MUSCLES; MYOBLASTS; PROTEASOME ENDOPEPTIDASE COMPLEX; REGENERATION; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 33646583549     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20804     Document Type: Article

References (32)

1. Bengal E, Ransone L, Scharfmann R, Dwarki VJ, Tapscott SJ, Weintraub H, Verma IM. 1992. Functional antagonism between c-Jun and MyoD proteins: A direct physical association. Cell 68(3):507-519.
2. Bois PR, Grosveld GC. 2003. FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts. EMBO J 22(5):1147-1157.
3. Bornman L, Polla BS, Gericke GS. 1996. Heat-shock protein 90 and ubiquitin: Developmental regulation during myogenesis. Muscle Nerve 19(5):574-580.
4. Braun T, Buschhausen-Denker G, Bober E, Tannich E, Arnold HH. 1989. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J 8(3):701-709.
5. Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M, Post M. 2000. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFβ3 (3). J Clin Invest 105(5):577-587.
6. Charge SB, Rudnicki MA. 2004. Cellular and molecular regulation of muscle regeneration. Physiol Rev 84(1):209-238.
7. Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr. 2000. NF-κB-induced loss of MyoD messenger RNA: Possible role in muscle decay and cachexia. Science 289(5488):2363-2366.
8. Hoppeler H, Vogt M, Weibel ER, Fluck M. 2003. Response of skeletal muscle mitochondria to hypoxia. Exp Physiol 88(1):109-119.
9. Huang LE, Gu J, Schau M, Bunn HF. 1998. Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95(14):7987-7992.
10. Iwai K, Yamanaka K, Kamura T, Minato N, Conaway RC, Conaway JW, Klausner RD, Pause A. 1999. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc Natl Acad Sci USA 96(22):12436-12441.
11. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY, Semenza GL. 1998. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α. Genes Dev 12(2):149-162.
12. Jiang BH, Zheng JZ, Vogt PK. 1998. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. Proc Natl Acad Sci USA 95(24):14179-14183.
13. Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. 2004. Hypoxia-inducible factor (HIF-1)α: Its protein stability and biological functions. Exp Mol Med 36(1):1-12.
14. Lele Z, Hartson SD, Martin CC, Whitesell L, Matts RL, Krone PH. 1999. Disruption of zebrafish somite development by pharmacologic inhibition of Hsp90. Dev Biol 210(1):56-70.
15. Lisztwan J, Imbert G, Wirbelauer C, Gstaiger M, Krek W. 1999. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes Dev 13(14):1822-1833.
16. Mabjeesh NJ, Post DE, Willard MT, Kaur B, Van Meir EG, Simons JW, Zhong H. 2002. Geldanamycin induces degradation of hypoxia-inducible factor 1α protein via the proteosome pathway in prostate cancer cells. Cancer Res 62(9):2478-2482.
17. Mason SD, Howlett RA, Kim MJ, Olfert IM, Hogan MC, McNulty W, Hickey RP, Wagner PD, Kahn CR, Giordano FJ, Johnson RS. 2004. Loss of skeletal muscle HIF-1α results in altered exercise endurance. PLoS Biol 2(10):E288.
18. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399(6733):271-275.
19. Minet E, Mottet D, Michel G, Roland I, Raes M, Remacle J, Michiels C. 1999. Hypoxia-induced activation of HIF-1: Role of HIF-1α-Hsp90 interaction. FEBS Lett 460(2):251-256.
20. Ohh M, Park CW, Ivan M, Hoffman MA, Kim TY, Huang LE, Pavletich N, Chau V, Kaelin WG. 2000. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Nat Cell Biol 2(7):423-427.
21. Rhodes SJ, Konieczny SF. 1989. Identification of MRF4: A new member of the muscle regulatory factor gene family. Genes Dev 3(12B):2050-2061.
22. Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R. 1993. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75(7):1351-1359.
23. Seagroves TN, Hadsell D, McManaman J, Palmer C, Liao D, McNulty W, Welm B, Wagner KU, Neville M, Johnson RS. 2003. HIF1α is a critical regulator of secretory differentiation and activation, but not vascular expansion, in the mouse mammary gland. Development 130(8):1713-1724.
24. Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA. 2000. Pax7 is required for the specification of myogenic satellite cells. Cell 102(6):777-786.
25. Semenza GL. 2003. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3(10):721-732.
26. Takarada Y, Takazawa H, Sato Y, Takebayashi S, Tanaka Y, Ishii N. 2000. Effects of resistance exercise combined with moderate vascular occlusion on muscular function in humans. J Appl Physiol 88(6):2097-2106.
27. Tomita S, Ueno M, Sakamoto M, Kitahama Y, Ueki M, Maekawa N, Sakamoto H, Gassmann M, Kageyama R, Ueda N, Gonzalez FJ, Takahama Y. 2003. Defective brain development in mice lacking the Hif-1α gene in neural cells. Mol Cell Biol 23(19):6739-6749.
28. Wright WE, Sassoon DA, Lin VK. 1989. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56(4):607-617.
29. Yun Z, Maecker HL, Johnson RS, Giaccia AJ. 2002. Inhibition of PPAR γ2 gene expression by the HIF-1-regulated gene DEC1/Stra13: A mechanism for regulation of adipogenesis by hypoxia. Dev Cell 2(3):331-341.
30. Yun Z, Lin Q, Giaccia AJ. 2005. Adaptive myogenesis under hypoxia. Mol Cell Biol 25(8):3040-3055.
31. Zelzer E, Levy Y, Kahana C, Shilo BZ, Rubinstein M, Cohen B. 1998. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1γ/ARNT. EMBO J 17(17):5085-5094.
32. Zhou J, Schmid T, Frank R, Brune B. 2004. PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1α from pVHL-independent degradation. J Biol Chem 279(14):13506-13513.